Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Hematologic Neoplasms 5Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3beta-Thalassemia 2Lymphoma 2Hodgkin Disease 2Anemia, Refractory, with Excess of Blasts 2Vasculitis, Central Nervous System 1Thalassemia 1Stiff-Person Syndrome 1Shwachman-Diamond Syndrome 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Rasmussen subacute encephalitis 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Opsoclonus-Myoclonus Syndrome 1Non-Malignant Neoplasm 1Neuromyelitis Optica 1Neurofibrosarcoma 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1cedazuridine 1Therapeutics 1Specimen Handling 1Pluvicto 1Peripheral Blood Stem Cell Transplantation 1Interleukin-8 1HuMax-IL8 1Granulocyte Colony-Stimulating Factor 1Genetic Counseling 1Filgrastim 1Exercise 1Emapalumab 1Decitabine 1DNA 1Cyclophosphamide 1Busulfan 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytopenia × thymoglobulin × 1 year × Clear all
NCT02143830 2025-11-12

RAFA

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
70 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Fanconi Anemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡